β¨ Health Notices
NEW ZEALAND GAZETTE, No. 77 β 1 SEPTEMBER 2016
Appointment / reappointment to the Pharmaceutical Management Agency
Pursuant to section 52(1) of the New Zealand Public Health and Disability Act 2000 and sections 28(1)(a) and 32(2) of the Crown Entities Act 2004 ("CE Act"), and notice given under section 28(2) of the CE Act, I have appointed
Professor Ross Lawrenson
and reappointed
Professor Jens Mueller
as members of the board of the Pharmaceutical Management Agency, for three-year terms of office commencing on 21 September 2016.
Dated at Wellington this 22nd day of August 2016.
HON DR JONATHAN COLEMAN, Minister of Health.
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Bortezomib Mylan
Bortezomib 3.5mg
Powder for injection
Mylan New Zealand Limited
Mylan Laboratories Limited, Bangalore, India
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Nuwiq
Simoctocog alfa 250IU
Powder for injection
Octapharma New Zealand Limited
Octapharma AB, Stockholm, Sweden
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Nuwiq
Simoctocog alfa 500IU
Powder for injection
Octapharma New Zealand Limited
Octapharma AB, Stockholm, Sweden
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Nuwiq
Simoctocog alfa 1000IU
Powder for injection
Octapharma New Zealand Limited
Octapharma AB, Stockholm, Sweden
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Nuwiq
Simoctocog alfa 2000IU
Powder for injection
Octapharma New Zealand Limited
Octapharma AB, Stockholm, Sweden
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Oxycodone Modified Release Tablets
Oxycodone hydrochloride 5mg
Modified release tablet
Mylan New Zealand Limited
Mylan Pharmaceuticals Inc, West Virginia, United States of America
44
Next Page →
β¨ LLM interpretation of page content
π₯ Appointment / reappointment to the Pharmaceutical Management Agency
π₯ Health & Social Welfare22 August 2016
Appointment, Reappointment, Pharmaceutical Management Agency, Board Members
- Ross Lawrenson (Professor), Appointed to the board
- Jens Mueller (Professor), Reappointed to the board
- HON DR JONATHAN COLEMAN, Minister of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Distribution, Consent, Pharmaceuticals
NZ Gazette 2016, No 77